| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1904472 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2016 | 8 Pages |
Abstract
Leptin administration within the subphysiological to physiological range diminishes atherosclerotic lesions. Leptin appears to mediate its antiatherogenic effects indirectly through reduction of hypercholesterolemia and liver steatosis, as well as upregulation of insulin-sensitizing and atheroprotective adiponectin.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Annett Hoffmann, Thomas Ebert, Nora Klöting, Janine Dokas, Franziska Jeromin, Beate Jessnitzer, Ralph Burkhardt, Mathias Fasshauer, Susan Kralisch,